GS
BRNS

Gilead Sciences’s Barinthus Biotherapeutics BRNS Stock Holding History

Gilead Sciences’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$92.5K Sell
99,478
-270,377
-73% -$251K 0.01% 14
2025
Q1 		$360K Sell
369,855
-250,496
-40% -$244K 0.03% 14
2024
Q4 		$749K Buy
+620,351
New +$749K 0.05% 14